Literature DB >> 29666343

Interleukin gene polymorphisms and susceptibility to HIV-1 infection: a meta-analysis.

Chrissa G Tsiara1, Georgios K Nikolopoulos, Niki L Dimou, Katerina G Pantavou, Pantelis G Bagos, Benedicta Mensah, Michael Talias, Georgia G Braliou, Dimitra Paraskeva, Stefanos Bonovas, Angelos Hatzakis.   

Abstract

Some subjects are repeatedly exposed to human immunodeficiency virus (HIV), yet they remain uninfected. This suggests the existence of host-resistance mechanisms. The current study synthesizes the evidence regarding the association between interleukin (IL) gene polymorphisms and HIV susceptibility. Medline, Scopus and the Web of Science databases were systematically searched, and a meta-analysis of case-control studies was conducted. Univariate and bivariate methods were used. The literature search identified 42 eligible studies involving 15,727 subjects. Evidence was obtained on eight single-nucleotide polymorphisms (SNPs): IL1A -889 C>T (rs1800587), IL1B +3953/4 C>T (rs1143634), IL4 -589/90 C>T (rs2243250), IL6 -174 G>C (rs1800795), IL10 -592 C>A (rs1800872), IL10-1082 A>G (rs1800896), IL12B -1188 A>C (rs3212227) and IL28B C>T (rs12979860). The IL1B +3953/4 C>T variant appears to increase the risk of HIV acquisition, under the assumption of a recessive genetic model (odds ratio (OR): 4.47, 95% CI: 2.35-8.52). The AA homozygotes of the IL10 -592 C>A SNP had an increased, marginally nonsignificant, risk (OR: 1.39, 95% CI: 0.97-2.01). It reached, however, significance in sub analyses (OR: 1.49, 95% CI: 1.04-2.12). Finally, the well-studied hepatitis C virus (HCV) infection IL28B (rs12979860) CT/TT genotypes were associated with a 27% decrease in HIV infection risk, especially in populations infected with HCV (OR: 0.73, 95% CI: 0.57-0.95). Interleukin signalling is perhaps important in HIV infection and some interleukin genetic variants may affect the risk of HIV acquisition. Approaches targeting specific genes and genome wide association studies should be conducted to decipher the effect of these polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29666343

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  121 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

2.  Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.

Authors:  Norma I Rallon; Clara Restrepo; Susanna Naggie; Mariola Lopez; Jorge Del Romero; David Goldstein; John McHutchison; Vincent Soriano; Jose M Benito
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

Review 3.  IL28B single nucleotide polymorphisms in the treatment of hepatitis C.

Authors:  Christian M Lange; Stefan Zeuzem
Journal:  J Hepatol       Date:  2011-03-25       Impact factor: 25.083

4.  Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.

Authors:  Slavé Petrovski; Jacques Fellay; Kevin V Shianna; Nicole Carpenetti; Johnstone Kumwenda; Gift Kamanga; Deborah D Kamwendo; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Myron S Cohen; David B Goldstein
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

5.  Hepatitis C viral load, genotype 3 and interleukin-28B CC genotype predict mortality in HIV and hepatitis C-coinfected individuals.

Authors:  Louise Nygaard Clausen; Karen Astvad; Steen Ladelund; Mette Vang Larsen; Kristian Schønning; Thomas Benfield
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

6.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

7.  Polymorphisms of IL-6 174 G/C, IL-10 -592 C/A and risk of HIV/AIDS among North Indian population.

Authors:  Ranbir Chander Sobti; Nega Berhane; Salih Abdul Mahedi; Rupinder Kler; Seyed Ali Hosseini; Vijish Kuttiat; Ajay Wanchu
Journal:  Mol Cell Biochem       Date:  2010-04       Impact factor: 3.396

8.  Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response.

Authors:  Susanna Naggie; Anu Osinusi; Antonios Katsounas; Richard Lempicki; Eva Herrmann; Alexander J Thompson; Paul J Clark; Keyur Patel; Andrew J Muir; John G McHutchison; Joerg F Schlaak; Martin Trippler; Bhavana Shivakumar; Henry Masur; Michael A Polis; Shyam Kottilil
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

9.  A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy.

Authors:  Hejun Yuan; Beverley Adams-Huet; Tianna Petersen; Nahid Attar; William M Lee; Mamta K Jain
Journal:  J Med Virol       Date:  2012-12       Impact factor: 2.327

10.  Genome-wide and fine-resolution association analysis of malaria in West Africa.

Authors:  Muminatou Jallow; Yik Ying Teo; Kerrin S Small; Kirk A Rockett; Panos Deloukas; Taane G Clark; Katja Kivinen; Kalifa A Bojang; David J Conway; Margaret Pinder; Giorgio Sirugo; Fatou Sisay-Joof; Stanley Usen; Sarah Auburn; Suzannah J Bumpstead; Susana Campino; Alison Coffey; Andrew Dunham; Andrew E Fry; Angela Green; Rhian Gwilliam; Sarah E Hunt; Michael Inouye; Anna E Jeffreys; Alieu Mendy; Aarno Palotie; Simon Potter; Jiannis Ragoussis; Jane Rogers; Kate Rowlands; Elilan Somaskantharajah; Pamela Whittaker; Claire Widden; Peter Donnelly; Bryan Howie; Jonathan Marchini; Andrew Morris; Miguel SanJoaquin; Eric Akum Achidi; Tsiri Agbenyega; Angela Allen; Olukemi Amodu; Patrick Corran; Abdoulaye Djimde; Amagana Dolo; Ogobara K Doumbo; Chris Drakeley; Sarah Dunstan; Jennifer Evans; Jeremy Farrar; Deepika Fernando; Tran Tinh Hien; Rolf D Horstmann; Muntaser Ibrahim; Nadira Karunaweera; Gilbert Kokwaro; Kwadwo A Koram; Martha Lemnge; Julie Makani; Kevin Marsh; Pascal Michon; David Modiano; Malcolm E Molyneux; Ivo Mueller; Michael Parker; Norbert Peshu; Christopher V Plowe; Odile Puijalon; John Reeder; Hugh Reyburn; Eleanor M Riley; Anavaj Sakuntabhai; Pratap Singhasivanon; Sodiomon Sirima; Adama Tall; Terrie E Taylor; Mahamadou Thera; Marita Troye-Blomberg; Thomas N Williams; Michael Wilson; Dominic P Kwiatkowski
Journal:  Nat Genet       Date:  2009-05-24       Impact factor: 38.330

View more
  6 in total

1.  Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, Greece.

Authors:  Leslie D Williams; Evangelia-Georgia Kostaki; Eirini Pavlitina; Dimitrios Paraskevis; Angelos Hatzakis; John Schneider; Pavlo Smyrnov; Andria Hadjikou; Georgios K Nikolopoulos; Mina Psichogiou; Samuel R Friedman
Journal:  Front Microbiol       Date:  2018-08-24       Impact factor: 5.640

2.  Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1.

Authors:  Sun Young Lee; Yong Kwang Park; Cheol-Hee Yoon; Kisoon Kim; Kyung-Chang Kim
Journal:  BMC Med Genomics       Date:  2019-01-09       Impact factor: 3.063

Review 3.  Inflammasome genetics and complex diseases: a comprehensive review.

Authors:  Fernanda Pereira Fernandes; Vinicius N C Leal; Dhemerson Souza de Lima; Edione C Reis; Alessandra Pontillo
Journal:  Eur J Hum Genet       Date:  2020-06-04       Impact factor: 4.246

4.  Association between polymorphisms in the interleukin-10 gene and susceptibility to human immunodeficiency virus-1 infection: A systematic review and meta-analysis.

Authors:  Dan-Hui Fu; Wen-Juan Deng; Zhi Yang; Sen Hong; Qian-Lin Ding; Yang Zhao; Jia Chen; Dan-Ke Su
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

5.  Inflammasome genetic variants are associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes.

Authors:  Nathalia Beatriz Ramos de Sá; Nara Cristina Silva de Souza; Milena Neira-Goulart; Marcelo Ribeiro-Alves; Tatiana Pereira Da Silva; Jose Henrique Pilotto; Valeria Cavalcanti Rolla; Carmem B W Giacoia-Gripp; Luzia Maria de Oliveira Pinto; Daniel Scott-Algara; Mariza Gonçalves Morgado; Sylvia Lopes Maia Teixeira
Journal:  Front Cell Infect Microbiol       Date:  2022-09-20       Impact factor: 6.073

6.  Short Communication: Genetic Variation in Human IL10 Proximal Promoter and Susceptibility to HIV-1 Infection in Mali, West Africa.

Authors:  Djeneba Dabitao; Mamadou Dembele; Michael Urbanowski; Bourahima Kone; Mamadou Wague; Nadie Coulibaly; Yeya Dit Sadio Sarro; Bocar Baya; Drissa Goita; Sounkalo Dao; Michael Belson; Sabra L Klein; Chad Achenbach; Jane L Holl; Mahamadou Diakite; Seydou Doumbia; Jay H Bream; William R Bishai; Souleymane Diallo; Robert L Murphy
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-23       Impact factor: 2.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.